Cargando…
From Nanoparticles to Cancer Nanomedicine: Old Problems with New Solutions
Anticancer nanomedicines have been studied over 30 years, but fewer than 10 formulations have been approved for clinical therapy today. Despite abundant options of anticancer drugs, it remains challenging to have agents specifically target cancer cells while reducing collateral toxicity to healthy t...
Autores principales: | Chiang, Chi-Ling, Cheng, Ming-Huei, Lin, Chih-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308137/ https://www.ncbi.nlm.nih.gov/pubmed/34209111 http://dx.doi.org/10.3390/nano11071727 |
Ejemplares similares
-
Old problem may have new solution
por: Zhaori, Getu
Publicado: (2018) -
Integrated pipeline for ultrasensitive protein detection in cancer nanomedicine
por: Cheng, Chi-An, et al.
Publicado: (2023) -
Advances in molecular phytodiagnostics – new solutions for old problems
por: Mumford, Rick, et al.
Publicado: (2006) -
Editorial: Genome Instability: Old Problem, New Solutions
por: Popovic, Marta, et al.
Publicado: (2022) -
Ascaridia galli - An old problem that requires new solutions
por: Höglund, Johan, et al.
Publicado: (2023)